128 related articles for article (PubMed ID: 20653713)
1. Use of BNP and bioimpedance to drive therapy in heart failure patients.
Di Somma S; De Berardinis B; Bongiovanni C; Marino R; Ferri E; Alfei B
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S56-61. PubMed ID: 20653713
[TBL] [Abstract][Full Text] [Related]
2. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department.
Di Somma S; Lalle I; Magrini L; Russo V; Navarin S; Castello L; Avanzi GC; Di Stasio E; Maisel A
Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):167-75. PubMed ID: 24477201
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S;
Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure.
Parrinello G; Paterna S; Di Pasquale P; Torres D; Fatta A; Mezzero M; Scaglione R; Licata G
J Card Fail; 2008 Oct; 14(8):676-86. PubMed ID: 18926440
[TBL] [Abstract][Full Text] [Related]
5. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure.
Massari F; Iacoviello M; Scicchitano P; Mastropasqua F; Guida P; Riccioni G; Speziale G; Caldarola P; Ciccone MM; Di Somma S
Heart Lung; 2016; 45(4):319-26. PubMed ID: 27117421
[TBL] [Abstract][Full Text] [Related]
7. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
9. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
[TBL] [Abstract][Full Text] [Related]
12. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
Oral I; Mistrík J; Náplava R
Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
[TBL] [Abstract][Full Text] [Related]
13. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
14. Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure.
Massari F; Scicchitano P; Iacoviello M; Valle R; Sanasi M; Piscopo A; Guida P; Mastropasqua F; Caldarola P; Ciccone MM
Heart Lung; 2019; 48(5):395-399. PubMed ID: 31113676
[TBL] [Abstract][Full Text] [Related]
15. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.
O'Neill JO; Bott-Silverman CE; McRae AT; Troughton RW; Ng K; Starling RC; Young JB
Am Heart J; 2005 Feb; 149(2):363-9. PubMed ID: 15846278
[TBL] [Abstract][Full Text] [Related]
17. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
18. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
Whellan DJ; Droogan CJ; Fitzpatrick J; Adams S; McCarey MM; Andrel J; Mather P; Rubin S; Bonita R; Keith S
J Card Fail; 2012 Feb; 18(2):107-12. PubMed ID: 22300777
[TBL] [Abstract][Full Text] [Related]
19. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure.
Alves FD; Souza GC; Aliti GB; Rabelo-Silva ER; Clausell N; Biolo A
Nutrition; 2015 Jan; 31(1):84-9. PubMed ID: 25466653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
